Compare PRU & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRU | A |
|---|---|---|
| Founded | 1875 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | PRU | A |
|---|---|---|
| Price | $114.70 | $138.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 15 |
| Target Price | $118.00 | ★ $162.80 |
| AVG Volume (30 Days) | 1.7M | ★ 2.3M |
| Earning Date | 02-03-2026 | 11-24-2025 |
| Dividend Yield | ★ 4.73% | 0.74% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | ★ 7.27 | 4.57 |
| Revenue | ★ $57,598,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | N/A | $8.00 |
| Revenue Next Year | $2.81 | $6.29 |
| P/E Ratio | ★ $15.70 | $30.28 |
| Revenue Growth | N/A | ★ 6.73 |
| 52 Week Low | $90.38 | $96.43 |
| 52 Week High | $123.88 | $160.27 |
| Indicator | PRU | A |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 39.84 |
| Support Level | $114.27 | $136.23 |
| Resistance Level | $118.31 | $139.19 |
| Average True Range (ATR) | 1.83 | 2.54 |
| MACD | -0.26 | -0.63 |
| Stochastic Oscillator | 52.66 | 15.66 |
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings and has around $1.4 trillion in assets under management.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.